These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9396708)

  • 1. Vaccines against Campylobacter jejuni.
    Scott DA
    J Infect Dis; 1997 Dec; 176 Suppl 2():S183-8. PubMed ID: 9396708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of live-attenuated Salmonella vaccines expressing Campylobacter antigens for control of C. jejuni in poultry.
    Buckley AM; Wang J; Hudson DL; Grant AJ; Jones MA; Maskell DJ; Stevens MP
    Vaccine; 2010 Jan; 28(4):1094-105. PubMed ID: 19853682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superoxide dismutase SodB is a protective antigen against Campylobacter jejuni colonisation in chickens.
    Chintoan-Uta C; Cassady-Cain RL; Al-Haideri H; Watson E; Kelly DJ; Smith DG; Sparks NH; Kaiser P; Stevens MP
    Vaccine; 2015 Nov; 33(46):6206-11. PubMed ID: 26458797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects.
    Tribble DR; Baqar S; Carmolli MP; Porter C; Pierce KK; Sadigh K; Guerry P; Larsson CJ; Rockabrand D; Ventone CH; Poly F; Lyon CE; Dakdouk S; Fingar A; Gilliland T; Daunais P; Jones E; Rymarchyk S; Huston C; Darsley M; Kirkpatrick BD
    Clin Infect Dis; 2009 Nov; 49(10):1512-9. PubMed ID: 19842970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Immunogenicity and Protective Efficacy of a
    Ramakrishnan A; Schumack NM; Gariepy CL; Eggleston H; Nunez G; Espinoza N; Nieto M; Castillo R; Rojas J; McCoy AJ; Beck Z; Matyas GR; Alving CR; Guerry P; Poly F; Laird RM
    mSphere; 2019 May; 4(3):. PubMed ID: 31043512
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral immunization with cholera toxin provides protection against Campylobacter jejuni in an adult mouse intestinal colonization model.
    Albert MJ; Mustafa AS; Islam A; Haridas S
    mBio; 2013 May; 4(3):e00246-13. PubMed ID: 23653448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of vaccine research and development for Campylobacter jejuni.
    Riddle MS; Guerry P
    Vaccine; 2016 Jun; 34(26):2903-2906. PubMed ID: 26973064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and immunoprotection of recombinant PEB1 in Campylobacter-jejuni-infected mice.
    Du LF; Li ZJ; Tang XY; Huang JQ; Sun WB
    World J Gastroenterol; 2008 Oct; 14(40):6244-8. PubMed ID: 18985818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of disease in ferrets fed an inactivated whole cell Campylobacter jejuni vaccine.
    Burr DH; Rollins D; Lee LH; Pattarini DL; Walz SS; Tian JH; Pace JL; Bourgeois AL; Walker RI
    Vaccine; 2005 Jul; 23(34):4315-21. PubMed ID: 16005742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant PorA, the major outer membrane protein of Campylobacter jejuni, provides heterologous protection in an adult mouse intestinal colonization model.
    Islam A; Raghupathy R; Albert MJ
    Clin Vaccine Immunol; 2010 Nov; 17(11):1666-71. PubMed ID: 20861330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live, attenuated Salmonella typhimurium vectoring Campylobacter antigens.
    Sizemore DR; Warner B; Lawrence J; Jones A; Killeen KP
    Vaccine; 2006 May; 24(18):3793-803. PubMed ID: 16135393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo phase variation and serologic response to lipooligosaccharide of Campylobacter jejuni in experimental human infection.
    Prendergast MM; Tribble DR; Baqar S; Scott DA; Ferris JA; Walker RI; Moran AP
    Infect Immun; 2004 Feb; 72(2):916-22. PubMed ID: 14742536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Campylobacter jejuni in broiler chickens: colonization and humoral immunity following oral vaccination and experimental infection.
    Rice BE; Rollins DM; Mallinson ET; Carr L; Joseph SW
    Vaccine; 1997 Dec; 15(17-18):1922-32. PubMed ID: 9413103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni.
    Maue AC; Poly F; Guerry P
    Hum Vaccin Immunother; 2014; 10(6):1499-504. PubMed ID: 24632556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
    Yuki N
    Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel immunoproteomics method for identifying in vivo-induced Campylobacter jejuni antigens using pre-adsorbed sera from infected patients.
    Hu Y; Shang Y; Huang J; Wang Y; Ren F; Jiao Y; Pan Z; Jiao XA
    Biochim Biophys Acta; 2013 Nov; 1830(11):5229-35. PubMed ID: 23850640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory considerations for Campylobacter vaccine development.
    Kopecko DJ
    J Infect Dis; 1997 Dec; 176 Suppl 2():S189-91. PubMed ID: 9396709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Campylobacter polysaccharide capsules: virulence and vaccines.
    Guerry P; Poly F; Riddle M; Maue AC; Chen YH; Monteiro MA
    Front Cell Infect Microbiol; 2012; 2():7. PubMed ID: 22919599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on Campylobacter jejuni vaccine development for preventing human campylobacteriosis.
    Jagusztyn-Krynicka EK; Łaniewski P; Wyszyńska A
    Expert Rev Vaccines; 2009 May; 8(5):625-45. PubMed ID: 19397419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Campylobacter jejuni enteritis.
    Baqar S; Rice B; Lee L; Bourgeois AL; El Din AN; Tribble DR; Heresi GP; Mourad AS; Murphy JR
    Clin Infect Dis; 2001 Sep; 33(6):901-5. PubMed ID: 11512097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.